Yoshitaka Sogawa, Akiko Shimizugawa, Takao Ohyama, Hiroaki Maeda, & Kazuki Hirahara. (2009). The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist. Elsevier.
Chicago Style (17th ed.) CitationYoshitaka Sogawa, Akiko Shimizugawa, Takao Ohyama, Hiroaki Maeda, and Kazuki Hirahara. The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist. Elsevier, 2009.
MLA (9th ed.) CitationYoshitaka Sogawa, et al. The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist. Elsevier, 2009.
Warning: These citations may not always be 100% accurate.